THALOMID is a prescription medicine used:\u00a0 to treat people who have been newly diagnosed with multiple myeloma (MM), and take along with the medicine dexamethasone. \uf0b7 to treat people who have moderate to severe new lesions of leprosy. THALOMID is not used by itself to treat the skin lesions when there is moderate to severe nerve pain. \uf0b7 to prevent and keep the skin lesions of leprosy from coming back (recurring). It is not known if THALOMID is safe and effective in children under 12 years of age. Active ingredient: thalidomide Inactive ingredients: pregelatinized starch and magnesium stearate.<\/p>\n
If thalidomide capsules are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n
THALOMID in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM). \u2022 THALOMID is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). THALOMID is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis. THALOMID is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.<\/p>\n
Approval Date: 1998 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cthalidomide capsules\u201d based on the information you provide.<\/p>\n
\nProprietary Name: On Request
\nActive Ingredient(s):\u00a0 thalidomide capsules
\nDosage Forms And Strengths: Capsules: 50 mg, 100 mg, 150 mg and 200 mg
\nCurrent indications: multiple myeloma
\nMedicine Approved By: \u2013<\/strong>\u00a0European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:<\/strong>\u00a0Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n